Targeting CB2 receptor with a novel antagonist reverses cognitive decline, neurodegeneration and pyroptosis in a TAU-dependent frontotemporal dementia mouse model
Ignacio Silva-Llanes, Silvia Rodríguez-López, Pedro González-Naranjo, Eric del Sastre, Manuela G. López, Juan A. Páez, Nuria E. Campillo, Isabel Lastres‐Becker
Topics & Concepts
Frontotemporal dementiaNeurodegenerationNeurosciencePyroptosisAntagonistDementiaMedicinePsychologyReceptorInternal medicineDiseaseInflammasomeCannabis and Cannabinoid ResearchTryptophan and brain disordersBipolar Disorder and Treatment